0001628280-24-032155.txt : 20240717 0001628280-24-032155.hdr.sgml : 20240717 20240717213243 ACCESSION NUMBER: 0001628280-24-032155 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOPKINS SHEILA CENTRAL INDEX KEY: 0001248574 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50644 FILM NUMBER: 241123573 MAIL ADDRESS: STREET 1: C/O WARNACO INC STREET 2: 90 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUTERA INC CENTRAL INDEX KEY: 0001162461 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770492262 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 94005 MAIL ADDRESS: STREET 1: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: ALTUS MEDICAL INC DATE OF NAME CHANGE: 20011119 4 1 wk-form4_1721266356.xml FORM 4 X0508 4 2024-07-15 0 0001162461 CUTERA INC CUTR 0001248574 HOPKINS SHEILA C/O CUTERA, INC. 3240 BAYSHORE BLVD. BRISBANE CA 94005 1 0 0 0 0 Stock Option (Right to Buy) 36.55 2024-07-15 4 D 0 3627 0 D 2023-07-13 2029-06-16 COMMON STOCK 3627 0 D Stock Option (Right to Buy) 1.54 2024-07-15 4 A 0 3627 0 A 2023-07-13 2029-06-16 COMMON STOCK 3627 3627 D Stock Option (Right to Buy) 15.83 2024-07-15 4 D 0 7770 0 D 2024-07-15 2030-07-14 COMMON STOCK 7770 0 D Stock Option (Right to Buy) 1.54 2024-07-15 4 A 0 7770 0 A 2024-07-15 2030-07-14 COMMON STOCK 7770 7770 D On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. /s/ Sheila Hopkins 2024-07-17